ZQ Capital completed the acquisition of Allergy Therapeutics for £48m.

Synopsis

ZQ Capital, an investment firm, completed the acquisition of Allergy Therapeutics, a specialty pharmaceutical company focused upon the diagnosis and treatment of allergy, for £48m.

Principals

target

Allergy Therapeutics

bidder

Zq Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.